AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-16203791_ITM" title="Facts and information about FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for the Treatment of Type 2 Diabetes.">FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for the Treatment of Type 2 Diabetes.</a>

Close Set up an RSS feed that alerts you when new articles from PR Newswire are available.

Frequently asked questions about RSS feeds

FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for the Treatment of Type 2 Diabetes.

PR Newswire

| July 31, 2006 | COPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

New product offers two commonly used doses in a single tablet, giving physicians and patients convenient dosing options

LINCOLNSHIRE, Ill., July 31 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (TPNA) announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for duetact(TM) (pioglitazone HCl and glimepiride), pronounced "Duet Act," for the treatment of type 2 diabetes.

Duetact combines ACTOS(R)(pioglitazone HCl) and glimepiride, two widely used diabetes medications with complementary actions, in a single tablet. ACTOS directly targets insulin resistance, a condition where the body does not efficiently use the insulin it produces; and glimepiride, a sulfonylurea, acts primarily by increasing…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Takeda Pharmaceuticals North America Shares Early Stage Data on Sleep Compound,...: Press release article from: PR Newswire May 21, 2003 700+ words
...development by Takeda Pharmaceuticals North America (TPNA) for chronic...cycle. About Takeda Pharmaceuticals North America Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly...


Takeda Pharmaceuticals North America Shares Early Stage Data on Ramelteon,...: Press release article from: PR Newswire October 20, 2003 700+ words
...development by Takeda Pharmaceuticals North America (TPNA) for transient...tissues. About Takeda Pharmaceuticals North America Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly...


Takeda Pharmaceuticals North America Provides Grant to Support Diabetes...: Press release article from: PR Newswire June 13, 2003 700+ words
...000 grant from Takeda Pharmaceuticals North America. The program will...Spanish. About Takeda Pharmaceuticals North America Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly...


American Diabetes Association, Takeda Pharmaceuticals North America Launch...: Press release article from: PR Newswire June 4, 2004 700+ words
...commitment from Takeda Pharmaceuticals North America. The 2004 award totals...Spanish. About Takeda Pharmaceuticals North America Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly...


American Diabetes Association, Takeda Pharmaceuticals North America Award Local...: Press release article from: PR Newswire July 1, 2004 700+ words
...commitment from Takeda Pharmaceuticals North America. About the American...Spanish. About Takeda Pharmaceuticals North America Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly...


Takeda Pharmaceuticals North America Names Vice President of Human Resources...: Press release article from: PR Newswire January 9, 2007 700+ words
...PRNewswire/ -- Takeda Pharmaceuticals North America, Inc., announced...department for Takeda Pharmaceuticals North America, Inc. and Takeda...president of Takeda Pharmaceuticals North America, Inc. "We look forward...


Late News.(Heineken USA plans to conduct an agency review)(Nissan North America...: Magazine article from: Advertising Age July 24, 2006 700+ words
...marketers from Y&R Detroit [detroit] Nissan North America, which lost a large chunk of staff in its headquarters...100M campaign for Rozerem [new york] Takeda Pharmaceuticals North America last week launched a $100 million campaign for...


Takeda Pharmaceuticals North America Names Chief Compliance Officer.: Press release article from: PR Newswire November 22, 2005 700+ words
...PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (TPNA) announced...president of Takeda Pharmaceuticals North America. "We're pleased...School of Law. Takeda Pharmaceuticals North America, Inc. Based in Lincolnshire...


Takeda Pharmaceuticals North America Selects Ninth House as Its Online Training...: Press release article from: Business Wire October 21, 2002 700+ words
...announced that Takeda Pharmaceuticals North America, Inc., a U.S...of Sales at Takeda Pharmaceuticals North America. "There is already...277-8200. Takeda Pharmaceuticals North America, Inc. Based in Lincolnshire...


Takeda Pharmaceuticals North America, Inc. Commits $1.425 Million to American...: Press release article from: PR Newswire June 5, 2006 700+ words
...commitment by Takeda Pharmaceuticals North America, Inc. to support...Scientific Affairs at Takeda Pharmaceuticals North America, Inc. "If we can...Spanish. About Takeda Pharmaceuticals North America, Inc. Based in Lincolnshire...

For more facts and information, see all results

Source: HighBeam Research, FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for the...

The AccessMyLibrary advertising network includes: